C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/44 (2006.01) A61K 31/47 (2006.01) A61K 31/495 (2006.01) A61K 31/53 (2006.01) C07D 241/24 (2006.01) C07D 401/04 (2006.01)
Patent
CA 2258752
Compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein E, Q, T, U, V, L, Z, X, W, M, Y and Y' are as set forth herein, are described. These compounds are useful as agents in the treatment of allergy, inflammation, autoimmune diseases, B-cell lymphomas, tumors, and the after effects of bone marrow transplantation.
L'invention concerne des composés représentés par la formule (I), où leurs sels pharmaceutiquement acceptables, E, Q, T, U, V, L, Z, X, W, M, Y et Y' étant définis. Ces composés sont des agents utiles dans le traitement des affections suivantes: allergies, inflammations, maladies auto-immunes, lymphomes malins, tumeurs et effets résiduels de la greffe de moelle osseuse.
Bober Loretta A.
Fine Jay S.
Grace Michael J.
Sherlock Margaret H.
Solomon Daniel M.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Schering Corporation
LandOfFree
Naphthyridines which affect il-4 and g-csf does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthyridines which affect il-4 and g-csf, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthyridines which affect il-4 and g-csf will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1766688